Kaapu, Kalle J
Murtola, Teemu J
Talala, Kirsi
Taari, Kimmo
Tammela, Teuvo LJ
Auvinen, Anssi
Article History
Received: 24 February 2016
Revised: 18 September 2016
Accepted: 22 September 2016
First Online: 18 October 2016
Competing interests
: TJ Murtola: lecture fee from Janssen-Cilag and MSD; K Taari: lecture fee GSK, paid consultancy for Abbvie, employee of Medivation, participation in the International Meeting with sponsors Astellas and Orion; TLJ Tammela: paid consultant for Astellas, GSK, Pfizer, Orion and Amgen; A Auvinen: lecture fee from MSD, paid consultancy for Epid Research. The other authors declare no conflict of interest.